How can wearables be used in clinical trials? FDA outlines best practices

The FDA has outlined best practices for using wearables and digital health technologies in clinical trials, emphasizing the need for validation and patient-centred measures to ensure meaningful health insights. This guidance aligns with the FDA's broader focus on incorporating real-world evidence and patient-generated data in regulatory decision-making for medical devices.

This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure, and 2 sources have reported it.